Skip to main content
Eleison Pharmaceuticals Inc. (ELSN)
Eleison Pharmaceuticals was planning to go public, but the IPO was withdrawn on Jun 29, 2023.
Stock Price: Pending
IPO price not available yet

Eleison Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20202019
Net Income
-6.4-1.72
Depreciation & Amortization
0.040.08
Share-Based Compensation
0.41-
Other Operating Activities
-1.160.65
Operating Cash Flow
-6.52-1
Share Issuance / Repurchase
11.16-
Debt Issued / Paid
0.170.27
Financing Cash Flow
11.330.27
Net Cash Flow
4.81-0.73
Free Cash Flow
-6.52-1
Free Cash Flow Margin
-651.68%-93.74%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).